SUSE

SUSE is a global leader in enterprise-grade open-source software solutions, specializing in Linux operating systems, Kubernetes management, and edge computing. While primarily a technology firm, SUSE is a critical infrastructure provider for the life sciences and healthcare sectors, serving all of the world's top 13 pharmaceutical companies. Its core products, including SUSE Linux Enterprise and SUSE Rancher, provide the high-performance computing (HPC) and secure container environments necessary for AI-driven drug discovery, genomic sequencing, and clinical data management. By offering a reliable and scalable open-source foundation, SUSE enables pharmaceutical organizations to modernize their IT stacks, accelerate research and development cycles, and maintain regulatory compliance. The company is currently a private entity owned by EQT AB, following its delisting from the Frankfurt Stock Exchange in 2023.